Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Evidence and Practice Questions Still Open for Parents of Teens With Acne

The 2026 AAD Annual Meeting in Denver gave parents of teens with acne current evidence and open practice questions. Pediatric specialists stressed early, individualized care because childhood acne and rosacea differ from adult disease.

Pediatric acne means breakouts in children and teens. Pediatric rosacea means persistent facial redness with bumps or visible vessels in children and teens. The American Academy of Dermatology reports the March 27-31 meeting covered both conditions as highlighted clinical topics meeting highlights.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What did the Denver presentation emphasize?
Which acne treatments do guidelines support for age 9 and older?
How should families approach oral antibiotics?
Is benzoyl peroxide still safe to keep at home?
What makes pediatric rosacea different?

What did the Denver presentation emphasize?

Pediatric dermatologist Dawn Eichenfield of Rady Children's Hospital-San Diego presented the pediatric update. She said pediatric acne and rosacea differ from adult disease and need early diagnosis with individualized treatment.

Early action matters because acne affects about 85% of adolescents and can impair self-esteem and mood. For parents, the practical point is to seek care when breakouts persist, scar, or distress the child, rather than waiting for adult patterns to emerge.

Which acne treatments do guidelines support for age 9 and older?

The AAD 2024 acne guideline strongly recommends topical benzoyl peroxide, retinoids, topical antibiotics, fixed-dose combinations, and oral isotretinoin for severe acne in patients age 9 and older updated acne guidance. Fixed-dose combinations put two actives in one product to simplify routines.

Age labeling widens teen options further. Medscape's summary of AAD guidance notes trifarotene 0.005% cream and sarecycline are labeled from age 9, while clascoterone 1% cream, most other retinoids and azelaic acid start at age 12. Parents can check this list before a visit:.

age 9 and older: trifarotene 0.005%, sarecycline, plus core guideline topicals
age 12 and older: clascoterone 1% and most other retinoids and azelaic acid

How should families approach oral antibiotics?

The same AAD guideline urges limiting oral antibiotics when possible. Dermatology Advisor's summary explains they should never be used alone, should be paired with benzoyl peroxide, and kept as short as possible, typically 3-4 months, to curb resistance.

Parents can ask the prescriber what the combination plan is and what defines the stop date. A short, paired course reduces resistance risk while treating moderate to severe inflammatory acne.

Is benzoyl peroxide still safe to keep at home?

FDA testing of 95 benzoyl peroxide products in March 2025 found over 90% had undetectable or very low benzene, prompting only limited voluntary recalls, Medscape reported in its FDA alert summary. Routine use was not the safety signal.

Heat exposure remains the open question. Families should store benzoyl peroxide at room temperature, avoid hot cars or steamy bathrooms, and discard discolored or expired products.

What makes pediatric rosacea different?

Pediatric rosacea is rare, with under 1% prevalence and no pediatric diagnostic criteria, according to a December 2025 retrospective study in JCM study report. Care is adapted from adult protocols around trigger and sun avoidance plus metronidazole, azelaic acid or ivermectin.

Eye symptoms need prompt evaluation. Parents should seek same-day eye care for red, gritty, swollen, painful eyes or vision changes alongside facial redness, and bring photos showing flushing triggers.